Patents Assigned to The New Industry Research Organization
-
Patent number: 8787075Abstract: Provided is memory which is capable of dynamically changing memory cell bit reliability and of switching the operating mode so as to accommodate process variations, thereby reducing the operating voltage. The memory is provided with a mode control line selection circuit for dividing mode control lines in to word units and using control line selection signals and global control signals to control the mode control lines divided into word units, and a word line selection circuit for dividing the word lines that control the conduction of switching unit into word units and using word line selection signals and global word signals to control the word lines divided into word units. The mode control line switching circuit is used to switch between a 1 bit/1 cell mode and a 1 bit/n cell mode in word units.Type: GrantFiled: August 14, 2011Date of Patent: July 22, 2014Assignee: The New Industry Research OrganizationInventors: Masahiko Yoshimoto, Hiroshi Kawaguchi, Yohei Nakata, Shunsuke Okumura
-
Patent number: 8524447Abstract: The object of the present invention is to provide a substance, which is easy to handle and enables the measurement of ATP with a high sensitivity regardless of the concentration of protein, and further a measuring method of ATP using the substance. Such object is solved with a fluorescence labelled fusion protein obtained by attaching two types of fluorescent substances of potential donor and acceptor for fluorescence resonance energy transfer (FRET) respectively to a protein which can cause structural changes depending on ATP binding, namely ? protein, which is the subunit of ATP synthetase, and further solved by contacting the fluorescence labelled fusion protein with a subject substance and then measuring the fluorescence spectra.Type: GrantFiled: March 25, 2008Date of Patent: September 3, 2013Assignee: The New Industry Research OrganizationInventors: Hiroyuki Noji, Hiromi Imamura, Ryota Iino, Yasuyuki Yamada
-
Publication number: 20130223137Abstract: Provided is memory which is capable of dynamically changing memory cell bit reliability and of switching the operating mode so as to accommodate process variations, thereby reducing the operating voltage. The memory is provided with a mode control line selection circuit for dividing mode control lines in to word units and using control line selection signals and global control signals to control the mode control lines divided into word units, and a word line selection circuit for dividing the word lines that control the conduction of switching unit into word units and using word line selection signals and global word signals to control the word lines divided into word units. The mode control line switching circuit is used to switch between a 1 bit/1 cell mode and a 1 bit/n cell mode in word units.Type: ApplicationFiled: August 14, 2011Publication date: August 29, 2013Applicant: The New Industry Research OrganizationInventors: Masahiko Yoshimoto, Hiroshi Kawaguchi, Yohei Nakata, Shunsuke Okumura
-
Patent number: 8238140Abstract: A memory wherein the bit reliability of the memory cells can be dynamically varied depending on the application or the memory status, the operation stability is ensured, and thereby a low power consumption and a high reliability are realized. Either a mode (a 1-bit/1-cell mode) in which one bit is composed of one memory cell or a mode (a 1-bit/n-cell mode) in which one bit is composed of n (n is two or more) connected memory cells is dynamically selected. When the 1-bit/n-cell mode is selected, the read/write stability of one bit is enhanced, the cell current during read is increased (read is speeded up), and a bit error, if occurs, is self-corrected. Especially, a pair of CMOS transistors and a control line for performing control so as to permit the CMOS transistors to conduct are added between the data holding nodes of n adjacent memory cells. With this, the word line (WL) is controlled, and thereby the operation stability is further improved.Type: GrantFiled: January 7, 2009Date of Patent: August 7, 2012Assignee: The New Industry Research OrganizationInventors: Masahiko Yoshimoto, Hiroshi Kawaguchi, Shunsuke Okumura, Hidehiro Fujiwara
-
Publication number: 20120175639Abstract: It is an object of the present invention to provide a method for manufacturing tantalum carbide which can form tantalum carbide having a prescribed shape using a simple method, can form the tantalum carbide having a uniform thickness even when the tantalum carbide is coated on the surface of an article and is not peeled off by a thermal history, tantalum carbide obtained by the manufacturing method, wiring of tantalum carbide, and electrodes of tantalum carbide. The tantalum carbide is formed on the surface of tantalum or a tantalum alloy by placing the tantalum or tantalum alloy in a vacuum heat treatment furnace, heat-treating the tantalum or tantalum alloy under a condition where a native oxide layer of Ta2O5 formed on the surface of tantalum or tantalum alloy is sublimated to remove the Ta2O5, introducing a carbon source into the vacuum heat treatment furnace, and then heat-treating.Type: ApplicationFiled: March 16, 2012Publication date: July 12, 2012Applicant: THE NEW INDUSTRY RESEARCH ORGANIZATIONInventors: Tadaaki Kaneko, Yasushi Asaoka, Naokatsu Sano
-
Patent number: 8084492Abstract: The present invention relates to a compound having a leukotriene (particularly leukotriene B4) inhibitory action, and useful for the prophylaxis or treatment of diseases such as allergy, asthma, inflammation, cancer and the like.Type: GrantFiled: November 18, 2005Date of Patent: December 27, 2011Assignee: The New Industry Research OrganizationInventors: Yoshitaka Oishi, Takehiko Yokomizo
-
Publication number: 20110252486Abstract: Disclosed is a cell which enables the reproduction of a cartilage tissue and has a proliferative ability. Also disclosed is a technique for providing a cell supply source which can be used in a definitive treatment of osteochondrosis deformans. A chondrocyte-like cell which has the same properties as those of a chondrocyte and can proliferate can be produced by selecting a combination of an Myc family gene and/or a Klf family gene and a SOX9 gene and introducing the combination into a somatic cell. The chondrocyte-like cell can be used for a medical purpose of cartilage regeneration.Type: ApplicationFiled: December 18, 2009Publication date: October 13, 2011Applicants: Osaka University, The New Industry Research OrganizationInventor: Noriyuki Tsumaki
-
Publication number: 20100233692Abstract: The object of the present invention is to provide a substance, which is easy to handle and enables the measurement of ATP with a high sensitivity regardless of the concentration of protein, and further a measuring method of ATP using the substance. Such object is solved with a fluorescence labelled fusion protein obtained by attaching two types of fluorescent substances of potential donor and acceptor for fluorescence resonance energy transfer (FRET) respectively to a protein which can cause structural changes depending on ATP binding, namely ? protein, which is the subunit of ATP synthetase, and further solved by contacting the fluorescence labelled fusion protein with a subject substance and then measuring the fluorescence spectra.Type: ApplicationFiled: March 25, 2008Publication date: September 16, 2010Applicants: THE NEW INDUSTRY RESEARCH ORGANIZATION, OSAKA UNIVERSITY, RIKKYO GAKUINInventors: Hiroyuki Noji, Hiromi Imamura, Ryota Iino, Yasuyuki Yamada
-
Patent number: 7723025Abstract: We paid attention to stearoyl-CoA desaturase gene, and investigated the relation between this gene and the unsaturated fatty acid content in beef fat. As a result, we found that the unsaturated fatty acid content was associated with the genotype of this gene, classified according to several single nucleotide polymorphisms (SNPs) on this gene. The present invention is a method to predict the unsaturated fatty acid content in beef (or milk) fat, on the basis of the genotype of bovine stearoyl-CoA desaturase, and useful prediction method for beef quality such as taste and texture.Type: GrantFiled: February 17, 2004Date of Patent: May 25, 2010Assignee: The New Industry Research OrganizationInventors: Soichi Tsuji, Hideyuki Mannen, Masaaki Taniguchi
-
Patent number: 7667477Abstract: Noise measuring circuitry of the present invention can be used to observe power supply noise waveforms, ground level noise waveforms, and a spatial distribution of noise at different positions in an integrated circuit having plural circuit blocks that perform digital signal processing, by being integrated into the integrated circuit (i.e., embedded), distributed at different positions. The distributed noise measuring circuitry can be manufactured using a CMOS process to manufacture the integrated circuit. The power supply noise measuring circuit and the ground level noise measuring circuit comprise a source follower, a select read out switch, and source-grounded amplifier. These noise measuring circuits can be configured by several (about 6) MOS transistors, so the layout for the measuring circuit can be small and can be achieved by using a logic gate circuit of the same size as that of a standard cell type logic gate circuit.Type: GrantFiled: August 20, 2004Date of Patent: February 23, 2010Assignee: The New Industry Research OrganizationInventor: Makoto Nagata
-
Patent number: 7638540Abstract: The present invention relates to a benzofuran compound of the formula (I) wherein each symbol is as defined in the description, a pharmaceutically acceptable salt thereof and the like. The compound of the present invention has superior leukotriene inhibitory action, BLT2 competitive inhibitory action, BLT2 blocking action, action for the prophylaxis or treatment of allergy, action for the prophylaxis or treatment of asthma and action for the prophylaxis or treatment of inflammation, and is useful as an agent for the prophylaxis or treatment of diseases such as allergic disease, asthma, inflammation and the like, and other diseases.Type: GrantFiled: May 28, 2004Date of Patent: December 29, 2009Assignee: The New Industry Research OrganizationInventors: Yoshitaka Oishi, Shigekatsu Kohno, Takehiko Yokomizo
-
Publication number: 20090124687Abstract: The present invention relates to a compound having a leukotriene (particularly leukotriene B4) inhibitory action, and useful for the prophylaxis or treatment of diseases such as allergy, asthma, inflammation, cancer and the like.Type: ApplicationFiled: November 18, 2005Publication date: May 14, 2009Applicant: THE NEW INDUSTRY RESEARCH ORGANIZATIONInventors: Yoshitaka Oishi, Takehiko Yokomizo
-
Publication number: 20090038538Abstract: Single crystal SiC, having no fine grain boundaries, a micropipe defect density of 1/cm2 or less and a crystal terrace of 10 micrometer or more is obtained by a high-temperature liquid phase growth method using a very thin Si melt layer. The method does not require temperature difference control between the growing crystal surface and a raw material supply polycrystal and preparation of a doped single crystal SiC is possible.Type: ApplicationFiled: October 14, 2008Publication date: February 12, 2009Applicant: THE NEW INDUSTRY RESEARCH ORGANIZATIONInventors: Tadaaki Kaneko, Yasushi Asaoka, Naokatsu Sano
-
Publication number: 20080113337Abstract: The present invention provides a method and device of quantitatively or qualitatively examining and judging the presence of virus infection, such as HIV, or the presence of prion infection by: irradiating a sample derived from an examinee or other animal with light having a wavelength in a range of 400 nm to 2500 nm or a wavelength in part of the range; detecting reflected light, transmitted light, or transmitted and reflected light to obtain an absorption spectral data; and analyzing the absorbance at all measurement wavelengths or at specific wavelengths in the absorption spectral data by using an analytical model prepared beforehand. The analytical model can be prepared by carrying out spectral measurement, with a perturbation being provided, and carrying out a multivariate analysis that brings out perturbation effects.Type: ApplicationFiled: November 10, 2005Publication date: May 15, 2008Applicants: THE NEW INDUSTRY RESEARCH ORGANIZATION, OSAKA UNIVERSITYInventors: Akikazu Sakudo, Roumiana Tsenkova, Kazuyoshi Ikuta, Takashi Onodera
-
Publication number: 20080105535Abstract: A new photocatalyst, which is high in visible light response, is great in quantum efficiency, and is more excellent in photocatalytic activity, is provided. A composite metal oxide, prepared combining two photocatalytic systems of TiO2 and BiVO4, including elements of Bi, Ti, and Vi as composition elements, can be a photocatalyst having a high activity under visible light. Particularly, BiTiVO6, which is obtained at a compounding ratio of 1:1, can be a photocatalyst having a remarkably high activity under visible light. Moreover, a composite metal oxide expressed by a general formula BiTiMO6 (in the formula, M represents at least one element selected from a group consisting of V, Nb, and Ta) can be a photocatalyst having a high activity under visible light.Type: ApplicationFiled: December 13, 2005Publication date: May 8, 2008Applicants: Osaka University, The New Industry Research OrganizationInventors: Yoshihiro Nakato, Haimei Liu, Ryuhei Nakamura
-
Patent number: 7321030Abstract: A promoter domain of 1816 bp or 441 bp in the upstream side of exon 1B of IAI.3B gene has a specifically high promoter activity in ovarian cancer cells. An adenovirus having this promoter domain inserted in the E1 domain thereof exhibits a specifically high cell proliferation inhibitory effect on ovarian cancer cells. Thus, it is efficacious in gene therapy for ovarian cancer.Type: GrantFiled: January 30, 2002Date of Patent: January 22, 2008Assignee: The New Industry Research OrganizationInventor: Katsuyuki Hamada
-
Publication number: 20080010696Abstract: By focusing attention on SREBP-1 gene, the relationship between this gene and the degree of unsaturation in beef body fat is examined. As a result, it is found out that this gene occurs as an “L-type” gene having a longer fifth intron and an “S-type” gene having a fifth intron shorter by 84 bases than the above one and these genotypes relate to the degree of unsaturation in beef body fat. A method of evaluating the content of unsaturated fatty acids in beef body fat based on these SREBP-1 genotypes is applicable to the evaluation of beef taste, texture and so on and, therefore, is industrially useful.Type: ApplicationFiled: February 3, 2006Publication date: January 10, 2008Applicant: THE NEW INDUSTRY RESEARCH ORGANIZATIONInventors: Soichi Tsuji, Hideyuki Mannen
-
Publication number: 20070141028Abstract: A cancer gene therapeutic drug of the present invention includes a carrier cell to be infected with an oncolytic virus, so as to make the oncolytic virus act on a tumor cell within a living body, wherein the carrier cell is selected from A549 cell, 293 cell, SW626 cell and HT-3 cell, showing a potent antitumor effect. Because of use of such cell line having high antitumor effect both in vitro and in vivo as the carrier cell, the cancer gene therapeutic drug provides more potent antitumor effect in comparison to those of conventional carrier cells.Type: ApplicationFiled: October 15, 2004Publication date: June 21, 2007Applicant: THE NEW INDUSTRY RESEARCH ORGANIZATIONInventors: Katsuyuki Hamada, Akinobu Goto, Toshiro Shirakawa
-
Publication number: 20070059501Abstract: It is an object of the present invention to provide a method for manufacturing tantalum carbide which can form tantalum carbide having a prescribed shape using a simple method, can form the tantalum carbide having a uniform thickness even when the tantalum carbide is coated on the surface of an article and is not peeled off by a thermal history, tantalum carbide obtained by the manufacturing method, wiring of tantalum carbide, and electrodes of tantalum carbide. The tantalum carbide is formed on the surface of tantalum or a tantalum alloy by placing the tantalum or tantalum alloy in a vacuum heat treatment furnace, heat-treating the tantalum or tantalum alloy under a condition where a native oxide layer of Ta2O5 formed on the surface of tantalum or tantalum alloy is sublimated to remove the Ta205, introducing a carbon source into the vacuum heat treatment furnace, and then heat-treating.Type: ApplicationFiled: July 30, 2004Publication date: March 15, 2007Applicant: THE NEW INDUSTRY RESEARCH ORGANIZATIONInventors: Tadaaki Kaneko, Yasushi Asaoka, Naokatsu Sano
-
Publication number: 20060249073Abstract: The present invention is a method suitable for heat treatment, or a heat treatment method for growing single crystal silicon carbide by a liquid phase epitaxial method, wherein a monocrystal silicon carbide substrate as a seed crystal and a polycrystal silicon carbide substrate are piled up, placed inside a closed container, and subjected to high-temperature heat treatment, by which very thin metallic silicon melt layer is interposed between the monocrystal silicon carbide substrate and the polycrystal silicon carbide substrate during heat treatment, and single crystal silicon carbide is liquid-phase epitaxially grown on the monocrystal silicon carbide substrate. The closed container is in advance heated to a temperature exceeding approximately 800° C.Type: ApplicationFiled: March 10, 2004Publication date: November 9, 2006Applicant: The new industry research organizationInventors: Yasushi Asaoka, Tadaaki Kaneko, Nakatsu Sano, Hiroshi Kawai, Tomohira Iwazaki, Seiji Yamaguchi, Hiroyuki Matsumoto, Toshiyuki Kouno